Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.
Hao PengLei ChenRui GuoYuan ZhangWen-Fei LiYan-Ping MaoYing SunFan ZhangLi-Zhi LiuLi TianJun MaPublished in: Chinese journal of cancer (2017)
A BED of 72 Gy to ENLNs is considerably sufficient to provide a clinical benefit to patients with N0-category NPC. Prospective studies are warranted to validate the findings in the present study.